EMAIL THIS PAGE TO A FRIEND

Scientific reports

Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor.


PMID 24759210

Abstract

A number of Bruton's tyrosine kinase (BTK) inhibitors are currently in development, yet it has been difficult to visualize BTK expression and pharmacological inhibition in vivo in real time. We synthesized a fluorescent, irreversible BTK binder based on the drug Ibrutinib and characterized its behavior in cells and in vivo. We show a 200 nM affinity of the imaging agent, high selectivity, and irreversible binding to its target following initial washout, resulting in surprisingly high target-to-background ratios. In vivo, the imaging agent rapidly distributed to BTK expressing tumor cells, but also to BTK-positive tumor-associated host cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

472654
N-Boc-2-aminoacetaldehyde, 95%
C7H13NO3